UNeMed

Omaha, United States Founded: 1991 • Age: 35 yrs
UNeMed produces high-quality medical devices and drugs for treating cancer, cardiovascular, and infectious diseases.

About UNeMed

UNeMed is a Healthcare company based in Omaha (United States) founded in 1991. UNeMed produces high-quality medical devices and drugs for treating cancer, cardiovascular, and infectious diseases. It operates on a B2B model. Its focus areas include Pharmaceuticals, Drug Manufacturing and Medical Devices and Treatments.

Company details

UNeMed, established in 1991, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and medical devices and treatments. UNeMed produces high-quality medical devices and drugs for treating cancer, cardiovascular, and infectious diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Apps and channels of UNeMed

its YouTube channel UNeMed Corporation has 53 subscribers and 30 videos.

UNeMed Corporation
YouTube 53 subscribers 30 videos Science & Technology
Open channel

Videos from UNeMed

The most watched videos on UNeMed's YouTube channel, UNeMed Corporation (53 subscribers). Click a video to play it here.

UNMC Intubation Shield
2.5K views
Suh Precision Syringe (EC)
1.9K views
Virtual Incision tests in humans | March 1, 2016 (KLKN-ABC)
727 views
Inside Innovation: Nasal sample collection kit
710 views

More on UNeMed Corporation.

Web traffic of UNeMed

The website of UNeMed (unemed.com) receives about 5.4K visits a month.

  • Monthly visits
    5.4K

    ▼ 5.4% vs previous month

Similar websites

Websites whose visitors overlap most with UNeMed. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
neuronexus.com
88%
7.8K#2,725,284View details

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as UNeMed (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 5.33 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Unemed

Premium access

Complete news archive for UNeMed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about UNeMed

UNeMed was founded in 1991.

UNeMed is headquartered in Omaha, United States. It is registered at Omaha, Nebraska, United States.

UNeMed, established in 1991, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and medical devices and treatments. UNeMed produces high-quality medical devices and drugs for treating cancer, cardiovascular, and infectious diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available